AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
SOTK

Sono-Tek Corporation Common Stock (SOTK) fair value

Technology · Scientific & Technical Instruments · NASDAQ · United States
$5.26+3.34%
Market cap $80MNext earnings 2026-10-14Updated Oct 20, 2026
Our verdict
Trades 124% above our fair value
Price
$5.26
Model fair valueConfidence: good
$2.35
Model range
$1.80 to $2.90
Fair value $2.35
Price $5.26
2 models fit Sono-Tek Corporation Common Stock and they disagree: 0 of 2 land within 15% of the average. The price is above every model.
Two or more of our models back this value.
Large premium(i)Bronze49
Valued as a cyclical company: P/E comparison, EV/EBITDA comparison, Discounted cash flow, and Graham number.
ACCE opinionSono-Tek Corporation Common Stock (SOTK)
Fair value (2 models)
$2.35
ACCE price target
$5.10
Rating
Overvalued
Horizon
12 months
Fair value published on 20 Oct 2026, 14:06 CEST; previously $2.40 since 18 Oct 2026, 00:00 CEST.
ACCE price target published on 21 Oct 2026, 01:52 CEST; previously $6.50 since 15 Oct 2026, 00:00 CEST.
Rating published on 20 Oct 2026, 14:06 CEST.
Price used: $5.26 at the close on 23 Oct 2026, 22:00 CEST.
Models: P/E comparison and Graham number.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
123.6% above
-55.3% to fair value
ACCE score
46
out of 100
Analysts
50% buy
2 covering
P/E
42.4x
forward 0.0x
1-year return
+14.6%
Dividend yield
0.00%

Sono-Tek Corporation Common Stock in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Sono-Tek makes ultrasonic coating systems, nozzles and generators that deposit thin, uniform films for medical device makers, semiconductor and battery manufacturers, and industrial customers. The moat is in the application know-how and installed process base rather than in scale, which is visible in a 52.5% gross margin. Growth has stalled, with revenue up only 1.3%, so the thesis rests on a recovery in orders from medical and electronics customers that the current numbers do not yet show. Operating margin of 7.3% and a 51.3x trailing P/E leave little room for error, and the stock sits outside any major index, which limits passive demand. It merits a deeper look mainly to test whether the order book and margin trajectory can re-accelerate.

AI-assisted·How I use AIWritten Oct 18, 2026
⚠ Investor warnings · 2 flagsAI-assisted·How I use AI
  • moderate
    Rich valuation
    P/E of 55.1 and EV/EBITDA of 20.6 leave little margin for error on a business growing revenue 10.3% YoY, with a 5-year revenue CAGR of only 7.1%.
  • moderate
    Insider selling outweighs buying
    Last 10 disclosed insider transactions total $0.22M in sales against $0.01M in buys, a modest but one-directional signal.

AI research notes

AI-assisted·How I use AIWritten Oct 13, 2026 · figures from 2026-05-31 · prices to Oct 23, 2026
Why it could do well
  • Revenue grew 10.3% year over year, ahead of the 7.1% average annual growth over five years.
  • The share count fell 0.2% over the last fiscal year, so each shareholder's slice of the company grew slightly.
Why it could disappoint
  • At a trailing P/E of 55.1x, the stock trades far above the sector median forward P/E of 29.3x.
  • Free cash flow of $3M gives a yield of only 2.7%, and return on equity is just 10.6%.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where SOTK's valuation models land
Price
$5.26
Model fair value
$2.35
Model range
$1.80 to $2.90
Fair value $2.35
Price $5.26
The price is above the whole model range.
Model
Fair value
Upside
Discounted cash flow
EV/EBITDA comparison
Graham number
P/E comparison
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Mixed50% buy · 2 covering analysts
● Strong buy 1● Buy 0● Hold 1● Sell 0● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
-14.6%
1 month
+8.2%
3 months
+1.3%
6 months
+11.9%
YTD
+27.4%
1 year
+14.6%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
21 Oct 2026, 01:52 CESTACCE price target$5.10$6.50$5.28
20 Oct 2026, 14:06 CESTFair value$2.35$2.40$5.47
20 Oct 2026, 14:06 CESTRatingOvervaluedfirst publication$5.47
18 Oct 2026, 00:00 CESTFair value$2.40$2.43$6.16
15 Oct 2026, 00:00 CESTACCE price target$6.50first publication$7.12
14 Oct 2026, 00:00 CESTFair value$2.43$2.89$7.16
10 Oct 2026, 00:00 CESTFair value$2.89$2.91$6.82
4 Oct 2026, 00:00 CESTFair value$2.91$2.86$6.20
11 Sept 2026, 00:00 CESTFair value$2.86$2.90$4.66
8 Sept 2026, 00:00 CESTFair value$2.90$2.86$5.02

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full SOTK page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth19Value40Quality54Momentum70Total46
Valuation
Trailing P/E
42.4x
Forward P/E
0.0x
PEG
no data
P/B
3.68x
EV / Revenue
2.8x
Book value/sh
$1.34
Enterprise value
$59M
Profitability
ROE
10.1%
FCF yield
3.78%
ROIC
7.5%
Health and risk
Debt / equity
no data
Dividend yield
0.00%
Beta
0.07

Price

+15.4% · 1Y

Ask anything about SOTK

Answered from Sono-Tek Corporation Common Stock fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 0% of peers
low 0.0x42.4xhigh 42.4x
ROEbetter than 100% of peers
low -672%10%high 10%
Div yieldbetter than 100% of peers
low 0.0%0.0%high 0.0%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
SOTK Sono-Tek Corporation Common Stock$5.26$2124% above42.4x10.1%5446
LACR.PA LACROIX Group SA€15.90--5.0x9.0%4375
WRAP Wrap Technologies Inc. Common Stock$1.22----107.7%4735
GNSS Genasys Inc. Common Stock$1.48----672.0%2522
V6C.DE Viscom SE€5.90----19.6%4352
ARBE Arbe Robotics Ltd. Ordinary Shares$0.43----83.2%2730
SGG.ST Sensys Gatso Group AB (publ)kr 43.70kr 8850% below12.6x6.7%6066

Sector report card

Where SOTK ranks against its sector peers on each metric.

Computing percentiles…
  • GlobeNewswire•Oct 14, 2026
    Sono-Tek Reports Fiscal Second Quarter and First Half 2027 Results Driven by Strong Medical Sector and Higher Value Production Systems
  • GlobeNewswire•Oct 7, 2026
    Sono-Tek Announces Fiscal Second Quarter and First Half 2027 Earnings Conference Call
  • GlobeNewswire•Sep 30, 2026
    Sono-Tek Announces Record $7.19 Million in Orders from Advanced Clean Energy Sector Customer
4 more press releases · full archive on Investor+.INVESTOR
38 filings of 40
October 2026
Oct 16
Form 4Insider transactionPeriod 2026-10-14
View on SEC →
Oct 14
10-QQuarterly reportPeriod 2026-08-31
View on SEC →
Oct 14
8-KCurrent reportPeriod 2026-10-14
View on SEC →
35 more filings + AI summaries on Investor+.INVESTOR